GlassScriptPhysician profile
Jonathan M Richman
NPI 1750347266
$9,012.67
in general payments reported to CMS, 2019-2025
69 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,482 · 2020: $768 · 2021: $1,392 · 2022: $1,837 · 2023: $1,566 · 2024: $782 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234 · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,233.83 |
| Education | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $614.37 | 2019-2024 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $572.77 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $538.91 | 2019-2024 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $509.37 | 2019-2023 | Austedo, Austedo Xr |
| Ucb, INC. | $491.56 | 2019-2023 | Fintepla |
| Abbvie INC. | $459.26 | 2021-2023 | |
| Genzyme Corporation | $392.95 | 2019-2023 | |
| Pfizer INC. | $346.86 | 2019-2025 | |
| Amgen INC. | $260.29 | 2019-2023 | Aimovig |
| Jazz Pharmaceuticals INC. | $256.43 | 2020-2023 | Epidiolex, Xywav |
| Biohaven Pharmaceutical Holding Company LTD. | $234.83 | 2022 | |
| Supernus Pharmaceuticals, INC. | $219.27 | 2019-2022 | |
| Upsher-Smith Laboratories LLC | $207.76 | 2019-2022 | |
| Acorda Therapeutics, INC | $197.85 | 2019-2023 | Inbrija |
| Lilly USA, LLC | $195.87 | 2019-2023 | Emgality, Reyvow |
Show all 69 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Richman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.